These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6299963)

  • 1. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus.
    Grose C; Edwards DP; Friedrichs WE; Weigle KA; McGuire WL
    Infect Immun; 1983 Apr; 40(1):381-8. PubMed ID: 6299963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles.
    Weigle KA; Grose C
    J Infect Dis; 1983 Oct; 148(4):630-8. PubMed ID: 6313814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII).
    Montalvo EA; Grose C
    Virology; 1986 Mar; 149(2):230-41. PubMed ID: 2418586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies.
    Keller PM; Lonergan K; Neff BJ; Morton DA; Ellis RW
    J Virol Methods; 1986 Sep; 14(2):177-88. PubMed ID: 3021804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic glycoproteins of laboratory and vaccine strains of Varicella-Zoster virus.
    Grose C; Edmond BJ; Friedrichs WE
    Infect Immun; 1981 Mar; 31(3):1044-53. PubMed ID: 6262245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens.
    Okuno T; Yamanishi K; Shiraki K; Takahashi M
    Virology; 1983 Sep; 129(2):357-68. PubMed ID: 6312679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoster in children with cancer: radioimmune precipitation profiles of sera before and after illness.
    Grose C
    J Infect Dis; 1983 Jan; 147(1):47-56. PubMed ID: 6296242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein.
    Grose C; Edwards DP; Weigle KA; Friedrichs WE; McGuire WL
    Virology; 1984 Jan; 132(1):138-46. PubMed ID: 6320530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.
    Takayama M
    Med Microbiol Immunol; 1994 Feb; 183(1):1-11. PubMed ID: 8202026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.
    Giller RH; Winistorfer S; Grose C
    J Infect Dis; 1989 Dec; 160(6):919-28. PubMed ID: 2555419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties.
    Montalvo EA; Parmley RT; Grose C
    J Virol; 1985 Mar; 53(3):761-70. PubMed ID: 2983087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
    Palumbo PE; Arvin AM; Koropchak CM; Wittek AE
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human monoclonal antibody against varicella-zoster virus glycoprotein III.
    Sugano T; Tomiyama T; Matsumoto Y; Sasaki S; Kimura T; Forghani B; Masuho Y
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2065-73. PubMed ID: 1654371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.
    Schmidt NJ; Gallo D
    J Med Virol; 1984; 13(1):1-12. PubMed ID: 6319583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
    Sauerbrei A; Wutzler P
    J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170.
    Arvin AM; Kinney-Thomas E; Shriver K; Grose C; Koropchak CM; Scranton E; Wittek AE; Diaz PS
    J Immunol; 1986 Aug; 137(4):1346-51. PubMed ID: 3016094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antibodies to varicella-zoster virus proteins in sera from the elderly.
    Vafai A; Mahalingam R; Zerbe G; Wellish M; Gilden DH
    Gerontology; 1988; 34(5-6):242-9. PubMed ID: 2851500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes.
    Keller PM; Neff BJ; Ellis RW
    J Virol; 1984 Oct; 52(1):293-7. PubMed ID: 6207311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor.
    Litwin V; Sandor M; Grose C
    Virology; 1990 Sep; 178(1):263-72. PubMed ID: 2167554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.